ADIM
MRTX

Alpha DNA Investment Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Alpha DNA Investment Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,423
Closed -$628K – 243
2023
Q3 		$628K Buy
+14,423
New +$628K 0.26% 79
2021
Q1 		– Sell
-5
Closed -$1K – 799
2020
Q4 		$1K Buy
+5
New +$1K ﹤0.01% 568